RITUXIMAB AND CYCLOPHOSPHAMIDE COMPARISON FOR EFFICACY AND SAFETY IN THE PATIENTS WITH SYSTEMIC SCLEROSIS ASSOCIATED WITH INTERSTITIAL LUNG DISEASE

被引：4
|
作者：
Koneva, Olga [1 ]
Ananyeva, Lidia P. [1 ]
Garzanova, Liudmila [1 ]
Desinova, Oxana [1 ]
Ovsyannikova, Olga [1 ]
Starovoytova, Mayya [1 ]
机构：
[1] VA Nasonova Res Inst Rheumatol, Moscow, Russia
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2019年 / 78卷
关键词：
D O I：
10.1136/annrheumdis-2019-eular.6816
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
OP0187
引用
收藏
页码：169 / 169
页数：1
相关论文
共 50 条
  • [31] Rituximab for the treatment of systemic sclerosis-interstitial lung disease
    Hughes, Michael
    Denton, Christopher P.
    Khanna, Dinesh
    RHEUMATOLOGY, 2021, 60 (02) : 489 - 491
  • [32] Successful treatment with rituximab in a Japanese patient with systemic sclerosis-associated interstitial lung disease resistant to oral steroid and cyclophosphamide
    Numajiri, Hiroko
    Yoshizaki, Ayumi
    Ebata, Satoshi
    Fukasawa, Takemichi
    Yamashita, Takashi
    Takahashi, Takehiro
    Taniguchi, Takashi
    Asano, Yoshihide
    Sato, Shinichi
    JOURNAL OF DERMATOLOGY, 2018, 45 (06): : E140 - E141
  • [33] RITUXIMAB AS RESCUE THERAPY IN ADVANCED PROGRESSIVE SYSTEMIC SCLEROSIS ASSOCIATED INTERSTITIAL LUNG DISEASE
    Kokosi, M.
    Saunders, P.
    Karagiannis, K.
    Chua, F.
    Maher, T. M.
    Renzoni, E. A.
    Wells, A. U.
    THORAX, 2015, 70 : A92 - A92
  • [34] INTERSTITIAL LUNG DISEASE AND HEART MANIFESTATIONS ASSOCIATED WITH SYSTEMIC SCLEROSIS DURING RITUXIMAB TREATMENT
    Garzanova, Liudmila
    Ananyeva, Lidia
    Koneva, Olga A.
    Ovsyannikova, Olga
    Starovoytova, Mayya
    Desinova, Oxana
    Shayakhmetova, Rushana
    Khelkovskaya-Sergeeva, Anna
    CHEST, 2023, 164 (04) : 3110A - 3111A
  • [35] Comparison of the effectiveness of cyclophosphamide and rituximab treatment in patients with systemic sclerosis–related interstitial lung diseases: a retrospective, observational cohort study
    Deniz Demir Yılmaz
    Sermin Borekci
    Benan Musellim
    Clinical Rheumatology, 2021, 40 : 4071 - 4079
  • [36] Safety and Tolerability of Pirfenidone in Patients with Systemic Sclerosis Interstitial Lung Disease
    Khanna, Dinesh
    Albera, Carlo
    Fischer, Aryeh
    Seibold, James R.
    Khalidi, Nader A.
    Raghu, Ganesh
    Chung, Lorinda
    Schiopu, Elena
    Chen, Dan
    Gorina, Eduard
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [37] Interstitial Lung Disease Associated with Systemic Sclerosis
    Mismetti, Valentine
    Si-Mohamed, Salim
    Cottin, Vincent
    SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 45 (03) : 342 - 364
  • [38] Systemic Sclerosis Associated Interstitial Lung Disease
    Steen, Virginia
    Weir, Nargues
    CURRENT RESPIRATORY MEDICINE REVIEWS, 2015, 11 (02) : 110 - 118
  • [39] Systemic sclerosis associated interstitial lung disease
    Xanthouli, P.
    Hermann, W.
    Hunzelmann, N.
    Kreuter, M.
    PNEUMOLOGE, 2018, 15 (06): : 383 - 395
  • [40] COMPARISON OF THE RITUXIMAB (RTM) EFFICACY IN MONOTHERAPY REGIMEN AND IN COMBINATION WITH IMMUNOSUPPRESSANTS IN SYSTEMIC SCLEROSIS (SSC) WITH INTERSTITIAL LUNG DISEASE (ILD)
    Koneva, O.
    Ananieva, L.
    Garzanova, L.
    Desinova, O.
    Ovsyannikova, O.
    Starovoytova, M.
    CHEST, 2020, 157 (06) : 374A - 374A
12345